name: Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

description: Stage II includes: T1, N0, M0, G2, G3. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)


Vulvar Solitary Fibrous Tumor

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: A rare solitary fibrous tumor that arises from the vulva.


name: Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8

description: Stage IIIB includes: T4, N0, M0, High Mitotic Rate. T4: Tumor measuring more than 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.)


Epithelioid fibrous histiocytoma

description: A morphologic variant of fibrous histiocytoma of the skin. It is characterized by the presence of epithelioid fibrohistiocytic cells.


Parotid Gland Kaposi Sarcoma

description: A Kaposi sarcoma arising from the parotid gland.


Recurrent Malignant Myoepithelioma

description: The reemergence of a malignant myoepithelioma after a period of remission.


Stage IA Soft Tissue Sarcoma AJCC v7

description: Stage IA includes: (T1a, N0, M0, G1, GX); (T1b, N0, M0, G1, GX).  T1a: Superficial tumor 5 cm or less in greatest dimension.  T1b: Deep tumor 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G1: Grade 1.  GX: Grade cannot be assessed. (AJCC 7th ed.)


name: Esophageal Malignant Peripheral Nerve Sheath Tumor

description: A malignant peripheral nerve sheath tumor that affects the esophageal wall.


Fascial fibroma

description: A benign fibrous tumor arising from the fascial connective tissue.


name: Stage IA Gastric Gastrointestinal Stromal Tumor

description: Stage IA includes: T1 or T2, N0, M0, Mitotic rate: Low.  T1: Tumor 2 cm or less in greatest dimension.  T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


Uterine Corpus Malignant PEComa

description: A malignant neoplasm with perivascular epithelioid cell differentiation arising from the uterine corpus. The neoplasm is usually a large size, and charcaterized by the presence of marked nuclear atypia, pleomorphism, increased mitotic activity, necrosis, and infiltrative margins.  The most common metastatic sites are lungs, lymph nodes, and bone. Patients present with a pelvic mass or abnormal bleeding.


name: Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8

description: Stage IV includes: IVA: T4, Any N, M0; IVB: Any T, Any N, M1. T4: Uterine corpus endometrial stroma sarcoma with tumor invading bladder or rectum. M0: No distant metastasis. M1: Distant metastasis (excluding adnexa, pelvic, and abdominal tissues). (from AJCC 8th Ed.)


name: Stage IV Childhood Rhabdomyosarcoma by Toronto Guidelines v2

description: Any site and any T, any N, M1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Advanced Synovial Sarcoma

description: A synovial sarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Benign Pilar-Associated Mesenchyme Neoplasm

description: A mesenchymal neoplasm arising from the pilar sheath of the hair follicle. It is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include fibrofolliculoma, perifollicular fibroma, pilar leiomyoma, and trichogenic myxoma.


name: Seminal Vesicle Mammary-Type Myofibroblastoma

description: An extramammary myofibroblastoma that affects the seminal vesicle.


Stage I Uterine Sarcoma AJCC v7

description: Stage I includes: T1, N0, M0.  T1: Tumor limited to the uterus.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)


Malignant Cervical Soft Tissue Neoplasm

description: A rare malignant mesenchymal neoplasm that arises from the cervix.


name: Skin Intermediate Fibrohistiocytic Neoplasm

description: A borderline fibrohistiocytic neoplasm arising from the dermis and extending to the subcutaneous tissues.


Head and Neck Epithelioid Hemangioma

description: An epithelioid hemangioma that arises from the head and neck. The most frequently affected sites are the forehead, preauricular region, and scalp.


Digestive System Sarcoma

description: A sarcoma that arises from the digestive system.


Stage III Uterine Sarcoma AJCC v7

description: Stage III includes: IIIA (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T1-T3, N1, M0).  T1: Tumor limited to the uterus. T2: Tumor extends beyond the uterus, within the pelvis.  T3: Tumor infiltrates abdominal tissues.  T3a: Tumor infiltrates abdominal tissues, one side. T3b: Tumor infiltrates abdominal tissues, more than one side.  N0: No regional lymph node metastasis. N1: Regional lymph node metastasis.  M0: No distant metastasis.  This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)


name: Peritoneal Desmoplastic Small Round Cell Tumor

description: A desmoplastic small round cell tumor that occurs in the abdominal and/or pelvic peritoneum.


name: Stage II Adult Soft Tissue Sarcoma AJCC v7

description: Stage II includes: IIA (T1a, N0, M0, G2, G3); (T1b, N0, M0, G2, G3); IIB (T2a, N0, M0, G2); (T2b, N0, M0, G2).  T1a: Superficial tumor 5 cm or less in greatest dimension.  T1b: Deep tumor 5 cm or less in greatest dimension.  T2a: Superficial tumor more than 5 cm in greatest dimension.  T2b: Deep tumor more than 5 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G2: Grade 2.  G3: Grade 3. (AJCC 7th ed.)


Intermediate Fibroblastic Neoplasm

description: A locally aggressive or rarely metastasizing neoplasm that arises from the soft tissues.  It is characterized by the presence of neoplastic spindle-shaped fibroblasts.


Gastric Lymphangioma

description: A lymphangioma arising from the stomach.


Bladder Malignant PEComa

description: A malignant perivascular epithelioid cell tumor arising from the bladder.


Leiomyoma, Epithelioid

description: A benign or malignant gastrointestinal stromal tumor with epithelioid morphology.


Giant Cell Angioblastoma

description: A rare, slow-growing, locally aggressive soft tissue tumor characterized by the presence of oval to spindle cells forming concentric aggregates around small vessels.  Giant multinucleated cells are also present.


name: Undifferentiated Sarcoma, Not Otherwise Specified

description: An undifferentiated soft tissue sarcoma which cannot be further characterized.


Stage IB Uterine Sarcoma AJCC v7

description: Stage IB includes: T1b, N0, M0.  T1b: For leiomyosarcoma and endometrial stromal sarcoma: tumor more than 5 cm in greatest dimension.  For adenosarcoma: tumor invades to less than half of the myometrium.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)


Vulvar Superficial Myofibroblastoma

description: An uncommon benign polypoid or nodular mesenchymal neoplasm that arises in the vulvar region. It is characterized by the presence of oval or spindle-shaped cells in a collagenous stroma and is separated from the epidermis by a variably thick Grenz zone.


AIDS-Related Cervical Kaposi Sarcoma

description: A Kaposi sarcoma arising from the cervix in patients who are infected with the human immunodeficiency virus.


Laryngeal Granular Cell Tumor

description: A granular cell tumor that arises from the larynx.


name: Childhood EWSR1-SMAD3-Positive Fibroblastic Tumor

description: An EWSR1-SMAD3-positive fibroblastic tumor that occurs during childhood.


Breast Angiolipoma

description: An angiolipoma that arises from the breast. The majority are located in the subcutaneous tissue overlying the breast parenchyma, rather than in breast parenchyma.


Stage IIIA Uterine Sarcoma AJCC v7

description: Stage IIIA includes: T3a, N0, M0.  T3a: Tumor infiltrates abdominal tissues, one side. N0: No regional lymph node metastasis. M0: No distant metastasis.  This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)


Skin Spindle Cell/Pleomorphic Lipoma

description: A spindle cell/pleomorphic lipoma arising from the skin.


Central Nervous System Angiolipoma

description: An angiolipoma that arises from the central nervous system.


name: Malignant Sinonasal Soft Tissue Neoplasm

description: A malignant mesenchymal neoplasm that arises from the nasal cavity and paranasal sinuses.


Sclerosing PEComa

description: A tumor with perivascular epithelioid cell differentiation characterized by the presence of cords of neoplastic cells in a densely collagenous stroma.


Bladder Solitary Fibrous Tumor

description: A solitary fibrous tumor that arises from the bladder. Most of these tumors are benign.


name: Uterine Corpus Central Primitive Neuroectodermal Tumor

description: A rare uterine corpus malignant small round cell tumor with neuroglial differentiation. The prognosis is poor.


alveolar rhabdomyosarcoma of prostate

description: A rare alveolar rhabdomyosarcoma arising from the prostate gland.


name: EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor of the Digestive System

description: EBV-positive inflammatory follicular dendritic cell/fibroblastic reticular cell tumor that arises from the digestive system.


Orbital Alveolar Soft Part Sarcoma

description: An alveolar soft part sarcoma involving the orbit. It usually occurs in children.


name: Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage

description: A term that refers to the staging of gastric and omental gastrointestinal stromal tumor (GIST), following the rules of the TNM AJCC v8 classification system. (from AJCC 8th Ed.)


name: Mixed Cell Type Gastrointestinal Stromal Tumor

description: A gastrointestinal stromal tumor composed of a mixture of neoplastic epithelioid and spindle cells.


name: Conventional Extraskeletal Myxoid Chondrosarcoma

description: A well differentiated extraskeletal myxoid chondrosarcoma.


Undifferentiated Stromal Sarcoma

description: An infiltrating high-grade malignant mesenchymal tumor arising from the uterine corpus, cervix, vagina, and ovary.


name: Orbit Extraskeletal Myxoid Chondrosarcoma

description: An extraskeletal myxoid chondrosarcoma that arises from the orbit. The orbit is the most frequently affected site for extraskeletal myxoid chondrosarcomas in the head and neck region.


name: Skin Atypical Lipomatous Tumor/Well Differentiated Liposarcoma

description: A rare atypical lipomatous tumor/well differentiated liposarcoma arising from the skin.


Myxoid leiomyoma

description: A leiomyoma characterized by the presence of abundant myxoid matrix.


Hemangioendothelioma of skin

description: A vascular proliferation arising from the skin.  It is characterized by the presence of prominent endothelial cells and formation of vascular channels.


name: Malignant Laryngeal Soft Tissue Neoplasm

description: A malignant mesenchymal neoplasm that arises from the larynx.


Degeneration of uterine fibroid

description: A morphologic variant of uterine corpus leiomyoma characterized by the presence of hyalinized or myxoid stroma, edema, cystic changes, hemorrhage, and calcifications.


Poorly Differentiated Synovial Sarcoma

description: A synovial sarcoma characterized by the presence of poorly differentiated morphological features and absence of spindle cells.


name: Stage III Childhood Rhabdomyosarcoma by Toronto Guidelines v2

description: Unfavorable site and (T1a, T2a, N1, M0); (T1b, T2b, Any N, M0). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Undifferentiated Epithelioid Sarcoma

description: An undifferentiated soft tissue sarcoma characterized by the presence of a malignant cellular infiltrate with epithelioid morphology.


Stage IV Soft Tissue Sarcoma AJCC v7

description: Stage IV includes: Any T, Any N, M1, Any G.  M1: Distant metastasis. (AJCC 7th ed.)


name: Gastrointestinal Stromal Tumor by AJCC v8 Stage

description: A term that refers to the staging of gastrointestinal stromal tumor (GIST), following the rules of the TNM AJCC v8 classification system. This staging system does not apply to pediatric GIST, familial GIST (germline mutant KIT or PDGFRA), or syndromic GIST (no AJCC staging system available). (from AJCC 8th Ed.)


name: Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8

description: Stage IIIB includes: (T2, N0, M0, High Mitotic Rate); (T3, N0, M0, High Mitotic Rate); (T4, N0, M0, High Mitotic Rate). T2: Tumor measuring more than 2 cm but not more than 5 cm. T3: Tumor measuring more than 5 cm but not more than 10 cm. T4: Tumor measuring more than 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.)


description: A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of poorly differentiated sarcomatous components.


name: Vaginal Low Grade Endometrioid Stromal Sarcoma

description: An infiltrating sarcoma that arises from the vagina.  It is characterized by the presence of cells that resemble endometrial stromal cells.


Fallopian Tube Soft Tissue Neoplasm

description: A benign or malignant mesenchymal neoplasm of the fallopian tube.  Representative examples include leiomyoma and leiomyosarcoma.


name: Childhood NTRK-Rearranged Spindle Cell Neoplasm

description: An NTRK-rearranged spindle cell neoplasm that occurs during childhood.


name: Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

description: Stage IIIA includes: T2, N0, M0, G2, G3. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)


Bladder Soft Tissue Neoplasm

description: A mesenchymal neoplasm that arises from the bladder.


Vulvar Angiomyofibroblastoma

description: An angiomyofibroblastoma arising from the vulva.


name: Tongue Ectomesenchymal Chondromyxoid Tumor

description: Ectomesenchymal chondromyxoid tumor that arises from the tongue, usually the anterior dorsal aspect.


Synovial sarcoma non-metastatic

description: Synovial sarcoma that is confined to a specific site without evidence of spread to other anatomic sites.


Superficial angiomyxoma

description: An angiomyxoma arising from the dermis or subcutaneous tissues.  It may recur following resection.


name: Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8

description: Stage III includes: IIIA: (T3, N0, M0, High Mitotic Rate); IIIB: (T4, N0, M0, High Mitotic Rate). T3: Tumor measuring more than 5 cm but not more than 10 cm. T4: Tumor measuring more than 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.)


Resectable Soft Tissue Sarcoma

description: Soft tissue sarcoma that is amenable to surgical resection.


Epithelioid sarcoma non-metastatic

description: Epithelioid sarcoma that is confined to a specific site without evidence of spread to other anatomic sites.


Desmoplastic fibroblastoma

description: A rare benign soft tissue neoplasm characterized by the presence of an abundant collagenous or myxocollagenous matrix, spindle-shaped, and stellate-shaped fibroblasts.  It usually presents as an asymptomatic, slowly growing subcutaneous mass. The most common sites of involvement are the upper arm, shoulder, and lower limb.


name: Uterine Corpus Leiomyoma, Mitotically Active Variant

description: A morphologic variant of uterine corpus leiomyoma characterized by an increased number of mitoses (up to 19 mitoses per 10 high-powered fields).


Sinonasal Soft Tissue Neoplasm

description: A mesenchymal neoplasm that arises from the nasal cavity and paranasal sinuses.


Recurrent Childhood Soft Tissue Sarcoma

description: The reemergence of soft tissue sarcoma in childhood after a period of remission.


Lacrimal Gland Myoepithelial Carcinoma

description: A carcinoma that arises from the lacrimal gland. It is characterized by the presence of a malignant cellular infiltrate exhibiting myoepithelial differentiation.


name: Optic Nerve Sheath Solitary Fibrous Tumor

description: A rare solitary fibrous tumor that arises from the optic nerve sheath.


Metastatic Malignant PEComa

description: A malignant PEComa that has spread from its original site of growth to another anatomic site.


name: Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8

description: Stage IA includes: T1a, N0, M0. T1a: Uterine corpus endometrial stroma sarcoma with tumor limited to the uterus, measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.)


name: Central Nervous System Inflammatory Myofibroblastic Tumor

description: A multinodular intermediate fibroblastic neoplasm affecting the central nervous system.  It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells.


name: Soft Tissue Sarcoma of the Trunk and Extremities

description: A soft tissue sarcoma that arises from the trunk or the extremities.


name: Stage II Gastric Gastrointestinal Stromal Tumor

description: Stage II includes: (T1, N0, M0, Mitotic rate: High); (T2, N0, M0, Mitotic rate: High); (T4, N0, M0, Mitotic rate: Low). T1: Tumor 2 cm or less in greatest dimension.  T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension.  T4: Tumor more than 10 cm in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


name: Recurrent Desmoplastic Small Round Cell Tumor

description: The reemergence of desmoplastic small round cell tumor after a period of remission.


Stromal Neoplasm

description: A benign or malignant mesenchymal neoplasm composed of stromal cells.  Representative examples include gastrointestinal stromal tumor, endometrial stromal sarcoma, and prostate stromal sarcoma.


NTRK-rearranged spindle cell neoplasm

description: An emerging rare group of soft tissue tumors, usually characterized by a monomorphic spindle cell infiltrate, stromal hyalinization, and frequent coexpression of S100 and CD34 by immunohistochemistry. Most tumors harbor NTRK1 fusions with a variety of partners. Rare cases involving NTRK2 and NTRK3 fusions have also been reported.


description: An extramammary myofibroblastoma that arises from the paratesticular region.


Classic Type Atypical Fibroxanthoma

description: A morphologic variant of atypical fibroxanthoma characterized by the presence of atypical mitotic figures, high mitotic activity, and pleomorphic cells.


Conjunctival Angiosarcoma

description: An angiosarcoma that arises from the conjunctiva.


Buccal Mucosa Lipoma

description: A benign adipose tissue neoplasm that arises from the buccal mucosa.


name: Soft Tissue Tumor of Uncertain Differentiation

description: A benign,intermediate, or malignant soft tissue neoplasm in which the line of differentiation is uncertain. Representative examples include neoplasm with perivascular epithelioid cell differentiation, alveolar soft part sarcoma, desmoplastic small round cell tumor, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, and synovial sarcoma.


Benign Gastric Soft Tissue Neoplasm

description: A mesenchymal neoplasm that arises from the stomach and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include leiomyoma, lipoma, and hemangioma.


name: Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8

description: Stage IV includes: (Any T, N1, M0, Any Mitotic Rate); (Any T, Any N, M1, Any Mitotic Rate). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)


Vulvar Prepubertal Fibroma

description: A rare, benign mesenchymal neoplasm that arises from the vulvar region, usually the labia majora of prepubertal girls. It presents as a slow-growing, unilateral painless mass. It is characterized by an infiltrative growth of bland spindle cells in a collagenous, edematous, or myxoid stroma. It may recur following incomplete excision.


name: Prostate Inflammatory Myofibroblastic Tumor

description: A rare inflammatory myofibroblastic tumor that arises from the prostate gland.


name: Locally Invasive Desmoid-Type Fibromatosis

description: Desmoid-type fibromatosis that has invaded the surrounding tissues.


Superficial Acral Fibromyxoma

description: A benign fibroblastic neoplasm that arises from acral sites, usually the periungual area of the digits.  It is characterized by the proliferation of spindled and stellate-shaped fibroblasts in the dermis in a myxoid or collagenous stroma.  Nuclear atypia is usually minimal.  It usually presents as a solitary and slow-growing dome-shaped mass on a digit. The recurrence rate is low.


name: Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

description: Stage IIIB includes: T3, T4, N0, M0, G2, G3. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)


name: Dermatofibrosarcoma protuberans with myoid differentiation

description: A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of areas of myofibroblastic differentiation.


Advanced Malignant PEComa

description: A malignant PEComa that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Head and Neck Epithelioid Hemangioendothelioma

description: A rare epithelioid hemangioendothelioma that arises from the head and neck. The most frequently affected sites are the oral cavity, soft tissue of the neck, and salivary glands.


name: Unresectable Malignant Gastrointestinal Stromal Tumor

description: Malignant gastrointestinal stromal tumor that is not amenable to surgical resection.


name: Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

description: Stage IB includes: T2, T3, T4, N0, M0, G1, GX. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.)


Childhood Rhabdomyosarcoma

description: An aggressive malignant mesenchymal neoplasm arising from skeletal muscle in children.  Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomic sites.


Pulmonary Artery Angiosarcoma

description: A malignant vascular neoplasm arising from the pulmonary artery.


Appendix Kaposi Sarcoma

description: A rare Kaposi sarcoma that arises from the appendiceal wall.


pleomorphic liposarcoma of skin

description: A rare pleomorphic liposarcoma arising from the skin.


name: Recurrent Gastrointestinal Stromal Tumor

description: The reemergence of a gastrointestinal stromal tumor after a period of remission.


Breast Atypical Myoepitheliosis

description: A neoplastic process characterized by the proliferation of spindle to cuboidal myoepithelial cells in and around small breast ducts exhibiting cytologic atypia and mitotic activity.


name: Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema

description: An angiosarcoma arising from the skin of the arm following radical mastectomy and resulting lymphedema.


name: Stage I Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2

description: Any T, N0, M0, G1 or GX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Vaginal Deep (Aggressive) Angiomyxoma

description: A locally infiltrating, non-metastasizing vaginal angiomyxoma.  It may recur following resection.


name: Malignant Soft Tissue Tumor of Uncertain Differentiation

description: A malignant soft tissue neoplasm in which the line of differentiation is uncertain.


Paratesticular Cellular Angiofibroma

description: A cellular angiofibroma that arises from the paratesticular region.


Jaw Desmoplastic Fibroma

description: A desmoplastic fibroma that arises from the jaw. It affects the mandible more often than the maxilla.


Skin Myoepithelioma

description: A benign skin neoplasm composed exclusively of myoepithelial cells.


name: Intermediate Sinonasal Soft Tissue Neoplasm

description: A mesenchymal neoplasm that arises from the sinonasal tract and is characterized by an increased risk of local recurrence and/or a low risk of metastasis.


name: Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential

description: A gastrointestinal stromal tumor arising from the stomach.  It is characterized by a maximum diameter greater than 5 cm and equal or less than 10 cm and no more than 5 mitotic figures per 50 high power fields.


Head and Neck Hemangioma

description: A hemangioma that arises from the head and neck. The most frequently affected sites are the oral cavity and sinonasal tract mucosa.


Vulvar Superficial Angiomyxoma

description: A vulvar angiomyxoma arising from the dermis or subcutaneous tissues. It may recur following resection.


description: A rare variant of dermatofibrosarcoma protuberans characterized by plaque-like growth, resembling plaque-like CD34-positive dermal fibroma.


name: Prostate Malignant Solitary Fibrous Tumor

description: A rare malignant solitary fibrous tumor that arises from the prostate gland.


Hepatobiliary Soft Tissue Neoplasm

description: A benign, intermediate, or malignant mesenchymal neoplasm that arises from the hepatobiliary system.


Thyroid Gland Leiomyoma

description: A leiomyoma that arises from the thyroid gland.


Atypical fibroxanthoma of skin

description: An intermediate cutaneous mesenchymal neoplasm of uncertain differentiation, usually affecting the actinic-damaged skin of the elderly.  The tumor presents as a single cutaneous nodule which is often ulcerated.  Microscopically, it is characterized by the presence of highly atypical cytologic features, pleomorphism and abundant mitotic figures. The vast majority of patients have an excellent prognosis following conservative therapy. Recurrences are infrequent, and metastasis is rare.


name: Skin Fibrous Histiocytoma, Fibroblastic Variant

description: A morphologic variant of fibrous histiocytoma of the skin. It is characterized by the presence of spindle-shaped fibrohistiocytic cells and associated acanthosis.


Soft Tissue Sarcoma by AJCC v7 Stage

description: A term that refers to the staging of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system.


description: An epithelioid hemangioendothelioma that arises from the nasal cavity and paranasal sinuses.


Intracranial Fibrous Histiocytoma

description: A benign fibrous histiocytoma involving the dura or cranial bone.


Intracranial lipoma

description: A rare benign adipose tissue neoplasm located in the intracranial region. It is a congenital hamartomatous malformation derived from the embryologic meninx primitiva.


name: Kaposi Sarcoma Related to Immunosuppressive Treatment

description: A Kaposi sarcoma that develops after immunosuppressive treatment.


Head and Neck Soft Tissue Neoplasm

description: A mesenchymal neoplasm that arises from the soft tissue of the head and neck.


name: Digestive System Inflammatory Myofibroblastic Tumor

description: A multinodular intermediate fibroblastic neoplasm arising from the digestive system. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells.


Pelvic Fibromatosis

description: Fibromatosis that occurs in the pelvis. It affects almost always females. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It recurs if incompletely resected but lacks metastatic potential.


Paratesticular Schwannoma

description: A schwannoma that arises from the paratesticular region.


Stage IIIC Uterine Sarcoma AJCC v7

description: Stage IIIC includes: T1-T3, N1, M0.  T1: Tumor limited to the uterus. T2: Tumor extends beyond the uterus, within the pelvis.  T3: Tumor infiltrates abdominal tissues.  N1: Regional lymph node metastasis.  M0: No distant metastasis.  This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)


Uterine Angiosarcoma

description: A malignant vascular neoplasm arising from the uterus.


Unresectable Synovial Sarcoma

description: Synovial sarcoma that is not amenable to surgical resection.


name: Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8

description: Stage III includes: IIIA: T3a, N0, M0; IIIB: T3b, N0, M0; IIIC: T1-3, N1, M0. T1: Uterine corpus endometrial stroma sarcoma with tumor limited to the uterus. T2: Uterine corpus endometrial stroma sarcoma with tumor extending beyond the uterus, within the pelvis. T3: Uterine corpus endometrial stroma sarcoma with tumor infiltrating abdominal tissues. T3a: Uterine corpus endometrial stroma sarcoma with tumor infiltrating abdominal tissues at one site. T3b: Uterine corpus endometrial stroma sarcoma with tumor infiltrating abdominal tissues at more than one site. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.)


Stage IVA Uterine Sarcoma AJCC v7

description: Stage IVA includes: T4, Any N, M0. T4: Tumor involves bladder or rectum.  M0: No distant metastasis.  This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)


Gastric sarcoma

description: A sarcoma that arises from the stomach. Representative examples include Kaposi sarcoma, leiomyosarcoma, and liposarcoma.


Recurrent Skin Angiosarcoma

description: The reemergence of skin angiosarcoma after a period of remission.


name: Intermediate Soft Tissue Tumor of Uncertain Differentiation

description: A soft tissue neoplasm of uncertain differentiation which is locally aggressive but rarely metastasizes.


Uterine Corpus Sarcoma by AJCC v8 Stage

description: A term that refers to the staging of uterine corpus sarcoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to leiomyosarcomas, endometrial stromal sarcomas, and adenosarcomas of the uterine corpus. It does not apply to carcinosarcomas which are staged according to the carcinomas and carcinosarcomas of the uterine corpus. (from AJCC 8th Ed.)


name: Cervical Low Grade Endometrioid Stromal Sarcoma

description: A very rare sarcoma that arises from the cervix and is characterized by the presence of cells that resemble endometrial stromal cells.


Alveolar soft part sarcoma recurrent

description: The reemergence of alveolar soft part sarcoma after a period of remission.


Hemangioma of salivary gland

description: A hemangioma that arises from a salivary gland. It occurs almost exclusively in the parotid gland.


Lipofibromatosis

description: A rare, slow-growing, painless tumor of infancy and early childhood that usually affects the distal extremities. It is characterized by the presence of alternating bands of mature adipose tissue and spindle-cell fibrous tissue, without destruction of the adipose tissue architecture. It does not metastasize, however the rate of local recurrences is high.


Malignant vascular tumor of skin

description: A malignant vascular neoplasm arising from blood vessels and lymphatics of the skin.


EWSR1-SMAD3-positive fibroblastic tumor

description: A benign fibroblastic neoplasm characterized by a fusion of exon 7 of EWSR1 gene with exon 5 of SMAD3 gene. Patients usually present with a small painless superficial tumor in the hands and feet. Morphologically, there is zonation with acellular hyalinized center and peripheral proliferation of fibroblastic spindle cells without atypia. It may recur following incomplete excision.


name: Unresectable Undifferentiated Pleomorphic Sarcoma

description: Undifferentiated pleomorphic sarcoma that is not amenable to surgical resection.


name: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

description: Stage III includes: IIIA: (T2, N0, M0, G2, G3); IIIB: (T3, T4, N0, M0, G2, G3). T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)


Atypical Ductal Breast Hyperplasia

description: A neoplastic process that arises from the terminal ductal lobular unit of the breast parenchyma.  It is usually solitary and confined to a single lobular unit.  It is characterized by the presence of a monomorphic epithelial proliferation in a cribriform, micropapillary, or solid growth pattern.  Focal architectural features of low grade ductal carcinoma in situ are present.  There is an increased risk for development of invasive breast carcinoma.


name: Grade 3 Pleura Infection with Unknown Absolute Neutrophil Count, CTCAE

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing


name: Skin Breakdown or Decubitus Ulcer, CTCAE


name: Grade 2 Skin Breakdown or Decubitus Ulcer, CTCAE


name: Grade 4 Skin Breakdown or Decubitus Ulcer, CTCAE


name: Grade 5 Skin Breakdown or Decubitus Ulcer, CTCAE


name: Conjunctival Carcinoma pN1 TNM Finding v8

description: Conjunctival carcinoma with regional lymph node metastasis. (from AJCC 8th Ed.)


name: Prostate Large Cell Neuroendocrine Carcinoma

description: An exceptionally rare neuroendocrine carcinoma that arises from the prostate gland.  It is characterized by the presence of malignant large cells.


naphthalenediamine

A naphthalene substituted with two amino groups.


aclacinomycin S zwitterion

A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin S. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).


CELLBIOSE

A cellobiose with an alpha-configuration at the anomeric position.


A xylose derivative that is beta-D-xylose in which the hydrogen of the anomeric hydroxy group is replaced by myricetin. it has been isolated from Mimosa diplotricha.


name: non-Hodgkin's lymphoma of intrathoracic lymph nodes

description: Evidence of non-Hodgkin lymphoma in the intrathoracic lymph nodes.


cysteamine S-phosphate

An organic thiophosphate that is the S-phospho derivative of cysteamine.


name: Unspecified Sequelae of Unspecified Cerebrovascular Disease

description: Evidence of unspecified sequelae of unspecified cerebrovascular disease.


name: Phenol-formaldehyde, cross-linked, triethylenetetramine activated


Postpartum Obstetric Thromboembolism

description: Presence of a blood clot in the maternal vascular system which originated from a distant site during the postpartum period.


Glu-Ile-Phe

A tripeptide composed of L-glutamic acid, L-isoleucine and L-phenylalanine joined in sequence by peptide linkages.


name: Clear Cell Calcifying Epithelial Odontogenic Tumor

description: A calcifying epithelial odontogenic tumor that contains a variable proportion of clear cells containing diastase-labile PAS-positive material that is consistent with glycogen.


name: Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified

description: Early T precursor acute lymphoblastic leukemia in which further genetic/molecular characterization is not available.


name: Ampulla of Vater Neuroendocrine Tumor G1

description: A well differentiated, low grade neoplasm with neuroendocrine differentiation that arises from the ampulla of Vater and the periampullary region. The mitotic count is less than 2 per 10 HPF.


An organic sodium salt that is the tetrasodium salt of 5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid


Testicular Cancer cM0 TNM Finding v8

description: Testicular cancer without evidence of distant metastasis. (from AJCC 8th Ed.)


name: Grade 1 Intraoperative Renal Injury, CTCAE

description: Primary repair of injured organ/structure indicated


name: Kaempferol 7,4'-dimethyl ether 3-(6''-(E)-p-coumarylglucoside)


Other Juvenile Arthritis, Right Hand

description: Evidence of other juvenile arthritis in the right hand not specified elsewhere.


name: 2-hydroxybenzoic acid [2-[[(1-methyl-2-pyrrolyl)-oxomethyl]amino]-2-oxoethyl] ester


2-hydroxy-2-methylbutyric acid

A branched-chain fatty acid that is 2-methylbutyric acid substituted at C-2 by a hydroxy group.


A linear trisaccharide, which forms part of the repeating unit of the Salmonella serogroup B oligosaccharide.


Osteolytic Lesions of Multiple Myeloma

description: A radiologic finding indicating the presence of multiple radiolucent osteolytic bone lesions observed in a patient with a diagnosis of multiple myeloma.


Solitary Lytic Metastatic Bone Lesion

description: A radiologic finding indicating the presence of solitary area of bone destruction that results from the spread of cancer to the bone(s).


name: Sicca Syndrome with Keratoconjunctivitis

description: Evidence of Sicca syndrome with keratoconjunctivitis.


The conjugate acid of cefepime.


L-glucose

The L-enantiomer of aldehydo-glucose.


aldehydo-glucose

The open chain form of glucose.


dTDP-beta-L-mycarose

A dTDP-sugar having beta-L-mycarose as the sugar component.


name: Rheumatoid Heart Disease with Rheumatoid Arthritis of Unspecified Ankle and Foot

description: Evidence of rheumatoid heart disease with rheumatoid arthritis of unspecified ankle and foot.


An indole alkaloid that is sarpagan bearing a hydroxy group at position 17.


Laryngeal Fistula

description: An abnormal communication between the larynx and another organ or cavity.


Pharyngocutaneous fistula

description: An abnormal communication between the skin and the pharynx.


Salivary Gland Fistula

description: An abnormal communication between a salivary gland and another organ or anatomic site.


External Auditory Canal Fistula

description: An abnormal communication between the external auditory canal and the adjacent tissues.


ALDH2 Gene Mutation Negative

description: A genetic finding indicating that ALDH2 gene variants have not been detected and biallelic (homozygous) expression of the wild-type allele (ALDH2*1) has been detected in a sample.


name: Grade 5 Oral Cavity or Gum Infection Documented Clinically or Microbiologically with Grade 3 or 4 Neutrophils, CTCAE


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3-oxooleic acid.


Locally Advanced Liposarcoma

description: A liposarcoma that has spread from its original site of growth to nearby tissues or lymph nodes.


Liposarcoma metastatic

description: A liposarcoma that has metastasized to a secondary site.


Metastatic Dedifferentiated Liposarcoma

description: Dedifferentiated liposarcoma that has spread from its original site of growth to another anatomic site.


Advanced Myxoid Liposarcoma

description: A myxoid liposarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Myxoid liposarcoma metastatic

description: Myxoid liposarcoma that has spread to other anatomic sites.


Advanced Dedifferentiated Liposarcoma

description: A dedifferentiated liposarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Metastatic Pleomorphic Liposarcoma

description: Pleomorphic liposarcoma that has spread from its original site of growth to another anatomic site.


Advanced Pleomorphic Liposarcoma

description: Pleomorphic liposarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Locally Advanced Dedifferentiated Liposarcoma

description: Dedifferentiated liposarcoma that has spread from its original site of growth to nearby tissues or lymph nodes.


Advanced Liposarcoma

description: A liposarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Recurrent Multinodular and Vacuolated Neuronal Tumor

description: The reemergence of multinodular and vacuolated neuronal tumor following a period of remission.


name: Adult Multinodular and Vacuolated Neuronal Tumor

description: A multinodular and vacuolated neuronal tumor that occurs in adults.


tetracosane

A straight-chain alkane containing 24 carbon atoms.


tricosane

A straight chain alkane containing 23 carbon atoms.


A branched C8 alkane, comprising heptane with a methyl group attached at C-4. It has been found in Amaranth seeds.


icosane

A straight chain alkane composed of 20 carbon atoms. It has been isolated from the leaves of Agave attenuata.


An alkane that is pentane substituted by a methyl group at positions 2,3 and 4. It is a constituent of gasoline.


docosane

A straight-chain alkane with 22 carbon atoms.


A branched alkane that is pentadecane carrying four methyl groups at at positions 2, 4, 6 and 10.


heptadecane

A straight-chain alkane with 17 carbon atoms. It is a component of essential oils from plants like Opuntia littoralis and Annona squamosa.


The (S)-enantiomer of 2,3-dimethylpentane.


An alkane that is heptane in which a hydrogen has been replaced by a methyl group at positions 2 and 4.


octadecane

A straight-chain alkane carrying 18 carbon atoms.


PENTADECANE

A straight-chain alkane with 15 carbon atoms. It is a component of volatile oils isolated from plants species like Scandix balansae.


An alkane that is decane in which the two methylene hydrogens at position 3 have been replaced by a methyl group and an ethyl group.


An alkane that is butane substituted by a methyl group at positions 2 and 3.


A long-chain alkane that is tridecane substituted by a methyl group at position 2. Metabolite observed in cancer metabolism.


tetratetracontane

A long-chain alkane consisting of an unbranched chain of 44 carbon atoms.


An alkane that is hexane in which the two methylene hydrogens at position 3 have been replaced by methyl groups.


nonadecane

A straight-chain alkane with 19 carbon atoms. It has been found as a component of essential oils isolated from Artemisia armeniaca.


An alkane that is decane substituted by a methyl group at positions 2,6 and 8. It is a combustion product of natural gas.


An alkane that is octane in which the two methylene hydrogens at position 3 have been replaced by methyl groups.


ETHANE

An alkane comprising of two carbon atoms.


triacontane

A straight-chain alkane with 30 carbon atoms.


An alkane that is undecane substituted by methyl groups at positions 3 and 8. Metabolite observed in cancer metabolism.


A branched alkane consisting of dodecane bearing three methyl substituents at positions 2, 6 and 11.


octadecanedioic acid

An alpha,omega-dicarboxylic acid that is octadecane in which both terminal methyl groups have been replaced by carboxy groups.


A branched alkane consisting of heptadecane bearing two methyl substituents at positions 2 and 6.


tetratriacontane

A long-chain alkane consisting of an unbranched chain of 34 carbon atoms.


long-chain alkane

Any alkane having a chain length of at least 13 carbon atoms.


An alkane that is pentane substituted by a methyl group at positions 2 and 3.


A branched alkane that is pentane carrying one methyl group at positions 2, and two methyl groups at position 3.


An alkane that is octane substituted by a methyl group at positions 2,3,6 and 7.


An  alkane that is  undecane substituted by methyl groups at positions 4 and 6.


hexacosane

A straight-chain alkane comprising of 26 carbon atoms.


The (R)-enantiomer of 2,3-dimethylpentane.


An alkane that is hexane substituted by a methyl group at position 3.


heptacosane

A straight-chain alkane with 27 carbon atoms.


An alkane that is dodecane substituted by methyl groups at positions 2, 7 and 10.


An alkane that is decane substituted by methyl groups at positions 2, 3, 5 and 8. Metabolite observed in cancer metabolism.


henicosane

An alkane that has 21 carbons and a straight-chain structure. It has been isolated from plants like Periploca laevigata and Carthamus tinctorius.


tritriacontane

A long-chain alkane consisting of an unbranched chain of 33 carbon atoms.


An alkane that is hexane substituted by a methyl group at positions 2,3 and 5.


A branched alkane that is undecane substituted at positions 2 and 5 by methyl groups.


NONACOSANE

A straight-chain alkane comprising of 29 carbon atoms.


isopentane

An alkane that is butane substituted by a methyl group at position 2.


A branched alkane that is heptane carrying two methyl groups each at positions 2 and 6, and one methyl group at position 4.


A branched alkane consisting of decane bearing three methyl substituents at positions 2, 6 and 7.


An alkane that is pentane which is substituted by a methyl group at position 3. It is used as a solvent in organic synthesis, as a lubricant and as a raw material for producing carbon black.


A branched alkane consisting of tridecane bearing a single methyl substituent at position 4.


A long-chain alkane that is heptadecane substituted by methyl groups at positions 2, 6, 10 and 15. Metabolite observed in cancer metabolism.


hexatriacontane

An alkane that has 36 carbons and a straight-chain structure.


pentacosane

An alkane consisting of an unbranched chain of 25 carbon atoms.


An alkane that is undecane substituted by a methyl group at position 4. Metabolite observed in cancer metabolism.


An alkane that is  octane substituted by methyl groups at positions 3 and 5. Metabolite observed in cancer metabolism.


A long-chain alkane that is heptadecane substituted by methyl groups at positions 2, 6, 10 and 14. Metabolite observed in cancer metabolism.


An alkane that is decane substituted by a methyl group at positions 2,4 and 6.


A branched alkane that is nonane carrying seven methyl substituents at positions 2, 2, 4, 4, 6, 8 and 8.


An alkane that is  dodecane substituted by methyl groups at positions 4 and 6. Metabolite observed in cancer metabolism.


An alkane that is pentane substituted by an ethyl group at position 3.


An alkane that is hexane carrying a methyl group at positions 2 and 4.


UNDECANE

A straight-chain alkane with 11 carbon atoms.


ISOBUTANE

An alkane that is propane substituted by a methyl group at position 2.


Grade 5 Ovarian Infection, CTCAE

description: Death


An amino disaccharide consisting of s-acetamido-2-deoxy-beta-D-galactopyranose and beta-D-galactopyranose residues joined in sequence by a (1->4) glycosidic bond.


phenylethanolamine

The simplest member of the class of  phenylethanolamines that is 2-aminoethanol bearing a phenyl substituent at the 1-position. The parent of the phenylethanolamine class.


A methyl ketone that is decane in which the methylene hydrogens at position 2 are replaced by an oxo group.


name: Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions

description: Evidence of hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions.


name: Fallopian Tube Cancer pNX TNM Finding v7

description: Fallopian tube cancer in which regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)


name: Fallopian Tube Cancer Pathologic Regional Lymph Nodes TNM Finding v7

description: A pathologic finding about one or more characteristics of fallopian tube cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.


name: Fallopian Tube Cancer pN0 TNM Finding v7

description: Fallopian tube cancer without regional lymph node metastasis. (from AJCC 7th Ed.)


name: Fallopian Tube Cancer pN1 TNM Finding v7

description: Fallopian tube cancer with regional lymph node metastasis. (from AJCC 7th Ed.)


A disaccharide derivative consisting of a alpha-D-mannosyl residue glycosidically linked to a 5-aminopentyl group and which carries at O-2 a beta-D-mannosyl residue.


Stage IV Ureter Cancer AJCC v8

description: Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invades adjacent organs, or through the kidney into the perinephric fat. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm in greatest dimension; or multiple lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)


name: Pheochromocytoma and Paraganglioma pM1 TNM Finding v8

description: Distant metastasis. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma TNM Finding v8

description: A finding about one or more characteristics of pheochromocytoma and paraganglioma, following the rules of the TNM AJCC v8 classification system. This classification system applies to the adrenal medulla pheochromocytomas and sympathetic paragangliomas. Parasympathetic paragangliomas are not staged because they are largely benign. This staging system does not apply to neuroendocrine tumors of the pancreas (are staged according to the classification for neuroendocrine tumors of the pancreas) and carotid body tumors (not staged). (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma cM1c TNM Finding v8

description: Distant metastasis to bone plus multiple other sites. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma pM1c TNM Finding v8


Pheochromocytoma pT1 TNM Finding v8

description: Pheochromocytoma measuring less than 5 cm in greatest dimension, with no extra-adrenal invasion. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma pT2 TNM Finding v8

description: Pheochromocytoma measuring 5 cm or more in greatest dimension or paraganglioma-sympathetic of any size, with no extra-adrenal invasion. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma cM1b TNM Finding v8

description: Distant metastasis to only distant lymph nodes/liver or lung. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma pM1b TNM Finding v8


name: Pheochromocytoma and Paraganglioma Pathologic TNM Finding v8

description: A pathologic finding about one or more characteristics of pheochromocytoma and paraganglioma, following the rules of the TNM AJCC v8 classification system.


name: Pheochromocytoma and Paraganglioma pTX TNM Finding v8

description: Primary tumor cannot be assessed. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma Clinical Distant Metastasis TNM Finding v8

description: A clinical finding about one or more characteristics of pheochromocytoma and paraganglioma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.


name: Pheochromocytoma and Paraganglioma Clinical TNM Finding v8

description: A clinical finding about one or more characteristics of pheochromocytoma and paraganglioma, following the rules of the TNM AJCC v8 classification system.


name: Pheochromocytoma and Paraganglioma cM0 TNM Finding v8

description: No distant metastasis. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma pN0 TNM Finding v8

description: No lymph node metastasis. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma Pathologic Distant Metastasis TNM Finding v8

description: A pathologic finding about one or more characteristics of pheochromocytoma and paraganglioma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.


name: Pheochromocytoma and Paraganglioma Pathologic Regional Lymph Nodes TNM Finding v8

description: A pathologic finding about one or more characteristics of pheochromocytoma and paraganglioma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.


name: Pheochromocytoma and Paraganglioma cM1 TNM Finding v8

description: Distant metastasis. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma cM1a TNM Finding v8

description: Distant metastasis to only bone. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma Pathologic Primary Tumor TNM Finding v8

description: A pathologic finding about one or more characteristics of pheochromocytoma and paraganglioma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of the primary tumor.


name: Pheochromocytoma and Paraganglioma pNX TNM Finding v8

description: Regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)


name: Pheochromocytoma and Paraganglioma pT3 TNM Finding v8

description: Tumor of any size with invasion into surrounding tissues (e.g., liver, pancreas, spleen, kidneys). (from AJCC 8th Ed.)


Late Relapse of Acute Myeloid Leukemia

description: Clinical and/or laboratory evidence of reemergence of acute myeloid leukemia greater than or equal to 12 months from diagnosis.


pemafibrate

A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-amine in which the amino hydrogens are replaced by 3-[(1R)-1-carboxypropoxy]benzyl and 3-(4-methoxyphenoxy)propyl groups. It is a selective peroxisome proliferator-activated receptor (PPAR)-alpha agonist that is used for the treatment of hyperlipidaemia.


13-(beta-D-glucosyloxy)docosanoic acid

A beta-D-glucoside consisting of docosanoic (behenic) acid having a beta-D-glucosyloxy group at position 13.


DULOXETINE HYDROCHLORIDE

A duloxetine hydrochloride in which the duloxetine moiety has S configuration.


Grade 5 Mucosal Infection, CTCAE

description: Death


name: 2-methoxybenzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester


Cleft Maxilla

description: A congenital abnormality consisting of a fissure in the midline of the upper jawbone.


3,5-di-O-caffeoyl quinic acid

A carboxylic ester that is the diester obtained by the condensation of the hydroxy groups at positions 3 and 5 of (-)-quinic acid with the carboxy group of trans-caffeic acid. Isolated from Brazilian propolis and Suaeda glauca, it exhibits hepatoprotective and cytotoxic activities.


Fallopian Tube Lymphoma

description: An exceedingly rare lymphoma that arises from the fallopian tube.


methyl p-coumarate acetate

A phenyl acetate obtained by the formal condensation of the hydroxy group of trans-4-coumaric acid with acetic acid.


name: Ovarian Cancer and Primary Peritoneal Carcinoma pTX TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma Pathologic TNM Finding v7

description: A pathologic finding about one or more characteristics of ovarian cancer or primary peritoneal carcinoma, following the rules of the TNM AJCC v7 classification system.


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT1b TNM Finding v7

description: Ovarian cancer limited to both ovaries; capsule intact, no tumor on ovarian surface.  No malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT2b TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma with extension to and/or implants on other pelvic tissues.  No malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT1 TNM Finding v7

description: Ovarian cancer limited to ovaries (one or both). (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma Pathologic Regional Lymph Nodes TNM Finding v7

description: A pathologic finding about one or more characteristics of ovarian cancer or primary peritoneal carcinoma, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT3 TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma involving one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma Pathologic Primary Tumor TNM Finding v7

description: A pathologic finding about one or more characteristics of ovarian cancer or primary peritoneal carcinoma, following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor.


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT1a TNM Finding v7

description: Ovarian cancer limited to one ovary; capsule intact, no tumor on ovarian surface.  No malignant cells in ascites or peritoneal washings.  (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma Pathologic Distant Metastasis TNM Finding v7

description: A pathologic finding about one or more characteristics of ovarian cancer or primary peritoneal carcinoma, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for ovarian cancer or primary peritoneal carcinoma.


name: Ovarian Cancer and Primary Peritoneal Carcinoma pNX TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma in which regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT3a TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma with microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor). (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT2 TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma involving one or both ovaries with pelvic extension. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT0 TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma with no evidence of primary tumor. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT3c TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma with peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension and/or regional lymph node metastasis. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT3b TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma with macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pT1c TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pN1 TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma with regional lymph node metastasis. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pN0 TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma without regional lymph node metastasis. (from AJCC 7th Ed.)


name: Ovarian Cancer and Primary Peritoneal Carcinoma pM1 TNM Finding v7

description: Ovarian cancer or primary peritoneal carcinoma with distant metastasis (excludes peritoneal metastasis). (from AJCC 7th Ed.)


name: Other Specified Rheumatoid Arthritis, Unspecified Hand

description: Evidence of other specified rheumatoid arthritis in an unspecified hand not specified elsewhere.


name: Soft Tissue Sarcoma Pathologic Regional Lymph Nodes TNM Finding v7

description: A pathologic finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.


name: Soft Tissue Sarcoma Pathologic TNM Finding v7

description: A pathologic finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system.


Soft Tissue Sarcoma pT0 TNM Finding v7

description: Soft tissue sarcoma with no evidence of primary tumor. (from AJCC 7th Ed.)


Soft Tissue Sarcoma pT1b TNM Finding v7

description: Soft tissue sarcoma with deep tumor measuring 5 cm or less in greatest dimension. (from AJCC 7th Ed.)


Soft Tissue Sarcoma pT2 TNM Finding v7

description: Soft tissue sarcoma with tumor measuring more than 5 cm in greatest dimension. (from AJCC 7th Ed.)


Soft Tissue Sarcoma pTX TNM Finding v7

description: Soft tissue sarcoma in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)


Soft Tissue Sarcoma pN0 TNM Finding v7

description: Soft tissue sarcoma without regional lymph node metastasis. (from AJCC 7th Ed.)


Soft Tissue Sarcoma pT2a TNM Finding v7

description: Soft tissue sarcoma with superficial tumor measuring more than 5 cm in greatest dimension. (from AJCC 7th Ed.)


name: Soft Tissue Sarcoma Pathologic Primary Tumor TNM Finding v7

description: A pathologic finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor.


Soft Tissue Sarcoma pN1 TNM Finding v7

description: Soft tissue sarcoma with regional lymph node metastasis.  Note: Presence of positive nodes (N1) in M0 tumors is considered Stage III. (from AJCC 7th Ed.)


Soft Tissue Sarcoma pT2b TNM Finding v7

description: Soft tissue sarcoma with deep tumor measuring more than 5 cm in greatest dimension. (from AJCC 7th Ed.)


Soft Tissue Sarcoma pM1 TNM Finding v7

description: Soft tissue sarcoma with distant metastasis. (from AJCC 7th Ed.)


Soft Tissue Sarcoma pT1a TNM Finding v7

description: Soft tissue sarcoma with superficial tumor measuring 5 cm or less in greatest dimension. (from AJCC 7th Ed.)


name: Soft Tissue Sarcoma Pathologic Distant Metastasis TNM Finding v7

description: A pathologic finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for soft tissue sarcoma.


Soft Tissue Sarcoma pT1 TNM Finding v7

description: Soft tissue sarcoma with tumor measuring 5 cm or less in greatest dimension. (from AJCC 7th Ed.)


name: Carcinoma in Situ of Skin of Left Lower Eyelid, Including Canthus

description: Evidence of carcinoma in situ of the skin of left lower eyelid including the canthus.


name: Cutaneous Squamous Cell Carcinoma of the Head and Neck pT3 TNM Finding v8

description: Cutaneous squamous cell carcinoma of the head and neck with tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression.  (from AJCC 8th Ed.)


Viral Breakthrough

description: The subject becomes viremic during the treatment period after a period of treatment-induced aviremia or has an increase in viral load from nadir above a predetermined threshold during the treatment period.


Ser-Asp-Lys-Pro

A tetrapeptide composed of L-serine, L-aspartic acid, L-lysine, and L-proline joined in sequence by peptide linkages.


N-tetracosanoylphytosphingosine

A phytoceramide compound having a tetracosanoyl group attached to the nitrogen atom.


clorprenaline

A racemate comprise of equimolar amounts of (R)- and (S)-clorprenaline. It is a beta2-adrenergic receptor agonist and a bronchodilator.


An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 5-amino-5-deoxy-3-dehydroshikimic acid; major species at pH 7.3.


A glycosylxylose that is D-xylopyranose in which the hydroxy group at position 2 has been converted into the corresponding beta-D-glucopyranosyl derivative.


glycosylxylose

Any xylose in which one of the hydroxy groups has undergone formal glycosylation.


A glycosylxylose consisting of beta-D-glucopyranose and beta-D-xylofuranose residues joined in sequence by a (1->5) glycosidic bond.


A glycosylxylose that is beta-D-xylopyranose in which the hydroxy group at position 3 has been converted into the corresponding beta-D-glucopyranoside.


xylobiose

A glycosylxylose that is D-xylopyranose having a beta-D-xylopyranosyl residue attached at position 4 via a glycosidic bond.


A glycosylxylose consisting of alpha-D-glucopyranose and D-xylopyranose residues joined in sequence by a (1->4) glycosidic bond.


A disaccharide consisting of a beta-D-galactopyranose residue joined to a D-xylopyranose residue by a (1->4) glycosidic bond. Used to diagnose hypolactasia (lactose intolerance as a result of lactase deficiency) via presence of D-xylose after cleavage by lactase.


A glycosylxylose consisting of beta-D-glucopyranose and beta-D-xylopyranose residues joined in sequence by a (1->4) glycosidic bond.


A disaccharide consisting of beta-D-glucopyranose and D-xylopyranose residues joined in sequence by a (1->4) glycosidic bond.


A disaccharide that is D-xylopyranose in which the hydroxy group at position 3 has been converted into the corresponding beta-D-galactopyranoside.


A glycosylxylose that is beta-D-xylopyranose in which the hydroxy group at position 2 has been converted to the corresponding 2-O-beta-D-glucopyranoside.


A glycosylxylose that is beta-D-xylopyranose in which the hydroxy group at position 4 has been converted into the corresponding beta-D-galactopyranoside.


A glycosylxylose consisting of beta-D-glucopyranuronic acid and D-xylopyranose residues joined in sequence by a (1->4) glycosidic bond.


A glycosylxylose consisting of a beta-D-glucopyranose residue and a D-xylopyranose residue joined in sequence by a (1->5) glycosidic bond.


A glycosylxylose consisting of a beta-D-galactopyranose residue and a beta-D-xylopyranose residue joined in sequence by a (1->3) glycosidic bond.


A disaccharide that is beta-D-xylose in which the hydroxy group at position 4 has been converted into the corresponding alpha-D-glucopyranoside.


A glycosylxylose consisting of beta-D-glucopyranuronic acid and beta-D-xylopyranose joined in sequence by a (1->4) glycosidic bond.


name: Other Specified Diabetes Mellitus with Other Skin Complications

description: Evidence of other specified diabetes mellitus with other skin complications not specified elsewhere.


A glycophytoceramide having a 4-O-{3-[4-(trifluoromethyl)phenyl]propyl}-alpha-D-galactosyl residue at the O-1 position and a hexacosanoyl group attached to the nitrogen. One of a series of an extensive set of 4"-O-alkylated alpha-GalCer analogues evaluated (PMID:30556652) as invariant natural killer T-cell (iNKT) antigens.


A glycosylceramide in which the glycosyl moiety is alpha-D-galactose and the ceramide is N-(hexacosanoyl)-11,12-methylene-C22-sphinganine.


2-methylbutanal oxime

An aldoxime derived from 2-methylbutanal.


(Z)-2-methylbutanal oxime

A 2-methylbutanal oxime in which the oxime double bond has Z geometry.


(E)-2-methylbutanal oxime

A 2-methylbutanal oxime in which the oxime double bond has E geometry.


(1E,2S)-2-methylbutanal oxime

An (E)-2-methylbutanal oxime that has S configuration at position 2.


(1Z,2S)-2-methylbutanal oxime

A (Z)-2-methylbutanal oxime that has S configuration at position 2.


A secondary alcohol that is butan-2-ol in which one of the methyl hydrogen atoms is substituted by chlorine.


Bacteriological Failure

description: There are indicators of bacterial infection in the individual who previously had an infection.


Bacteriological Finding

description: Objective evidence of bacterial infection perceptible to the examiner by laboratory procedure.


Bacteria Present

description: Confirmatory presence of bacterial microorganisms.


Bacteriological Cure

description: There are no indicators of bacterial infection in an individual who previously had an infection.


Helicobacter pylori Status

description: The finding of whether an individual is infected with the H.pylori bacteria.


NEOMETHYMYCIN

A twelve-membered macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.


Cu(I)-S-Mo(IV)(=O)O-NBIC Cluster

A metal-sulfur-oxygen cluster with formula C5H9CuMoNO2S. Bound ligand.


An isochromene that is 3,4-dihydroisochromene-5,6-diol bearing additional aminomethyl and 1-adamantyl substituents at positions 1 and 3 respectively (the 1R,3S-diastereomer). Potent and selective dopamine D1-like receptor agonist (pEC50 values are 8.97 and < 5 for D1-like and D2-like receptors respectively). Displays anti-Parkinsonian activity following oral administration in vivo.


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of trans-dec-3-enoic acid.


name: 6-amino-5,7,7-tricyano-8-pyridin-4-yl-1,3,8,8a-tetrahydroisoquinoline-2-carboxylic acid (phenylmethyl) ester


The intermediate in the biosynthesis of vitamin B12 from uroporphyrinogen III in which eight methyl groups have been introduced into the tetrapyrrole framework, together with ring contraction and decarboxylation.


A quercetin O-glucoside that is quercetin attached to a beta-D-sophorosyl residue at position 3 via a glycosidic linkage.


The L-enantiomer of 3-oxoalanine.


name: Grade 3 Lower Extremity Vein Injury, CTCAE


name: Grade 4 Lower Extremity Vein Injury, CTCAE


name: Grade 2 Lower Extremity Vein Injury, CTCAE


name: Grade 1 Lower Extremity Vein Injury, CTCAE


name: Grade 5 Lower Extremity Vein Injury, CTCAE


Gastric melanoma

description: A melanoma that arises from mucosa of the stomach.


A 3-oxo-5alpha-steroid formed from 11-deoxycorticosterone by reduction across the C4-C5 double bond.


ROPIVACAINE HYDROCHLORIDE

The anhydrous form of (S)-ropivacaine hydrochloride.


(E)-dimethomorph

An enamide resulting from the formal condensation of (2E)-3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acrylic acid with the amino group of morpholine. The agricultural fungicide dimethomorph is a mixture of (E)- and (Z)-dimethomorph; only the Z isomer has fungicidal activity.


name: Grade 2 Oral Cavity or Gum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


name: Oral Cavity or Gum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


name: Grade 5 Oral Cavity or Gum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


name: Grade 4 Oral Cavity or Gum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


name: Grade 3 Oral Cavity or Gum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


straight-chain fatty acid

Any fatty acid whose skeletal carbon atoms form an unbranched open chain.


but-3-enoic acid

That isomer of butenoic acid having the double bond at position C-3.


(9Z,12E)-hexadecadienoic acid

A hexadecadienoic acid having two double bonds located at positions 9 and 12 (the 9Z,12E-geoisomer).


all-cis-icosa-5,8,14-trienoic acid

An icosatrienoic acid with three cis-double bonds at positions 5, 8 and 14.


pent-3-enoic acid

A pentenoic acid having the double bond at position 3.


hydroxypalmitic acid

A hydroxy fatty acid that is palmitic (hexadecanoic) acid substituted with one hydroxy group.


A HETrE that is (8Z,10E,14Z)-icosatrienoic acid in which the hydroxy group is located at the 12(S)-posiiton.


A hydroxyeicosatrienoic acid that consists of 6E,8Z,11Z-eicosatrienoic acid bearing a 5-hydroxy substituent.


7,10,13,16-docosatetraenoic acid

A docosatetraenoic acid in which the four double bonds are located at positions 7, 10, 13 and 16 (geometry unspecified).


trans-dec-3-enoic acid

A decenoic acid having a trans- double bond at position 3.


hexacosahexaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any six positions of a 26-carbon straight chain.


parinaric acid

An octadecatetraenoic acid containing a conjugated system of  double bonds at positions 9, 11, 13 and 15.


linolenic acid

A two-membered subclass of octadecatrienoic acid comprising the (9Z,12Z,15Z)- and (6Z,9Z,12Z)-isomers. Linolenic acids are nutrients essential to the formation of prostaglandins and are also used in making paints and synthetic resins.


6-hydroxyhexanoic acid

An omega-hydroxy fatty acid comprising hexanoic acid having a hydroxy group at the 6-position.


octadecadiynoic acid

Any C18 straight-chain fatty acid having two C#C triple bonds.


5-hydroxypentanoic acid

An omega-hydroxy fatty acid consisting of pentanoic acid carrying a hydroxy group at C-5.


(15R)-15-hydroxypalmitic acid

An (omega-1)-hydroxy fatty acid that is hexadecanoic acid in which the 15-pro-R hydrogen is replaced by a hydroxy group.


2E-DECENOIC ACID

A 2-decenoic acid having its double bond in the trans configuration. It is an intermediate metabolite in the fatty acid synthesis.


dotriacontapentaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any five positions of a 32-carbon straight chain.


8-hydroxyoctanoic acid

An omega-hydroxy fatty acid that is caprylic acid in which one of the hydrogens of the terminal methyl group is replaced by a hydroxy group.


trioxilin

Any icosatrienoic acid having three hydroxy substituents.


(5Z,11Z,14Z)-icosatrienoic acid

An icosatrienoic acid in which the three double bonds have Z configuration and are located at positions 5, 11 and 14.


triacontahexaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any six positions of a 30-carbon straight chain.


octadecynoic acid

Any C18, straight-chain, monounsaturated fatty acid having a C#C triple-bond at any position.


(E,Z,E)-octadeca-9,11,13-trienoic acid

A  9,11,13-octadecatrienoic acid having its double bonds in trans, cis and trans configurations, respectively.


A very long-chain omega-3 fatty acid that is octatriacontanoic acid having six double bonds located at positions 23, 26, 29, 32 and 35 (the 23Z,26Z,29Z,32Z,35Z-isomer).


11-tetradecenoic acid

A tetradecenoic acid having its double bond in the 11-position.


A very long-chain omega-3 fatty acid that is octacosanoic acid having six double bonds located at positions 10, 13, 16, 19, 22 and 25 (the 10Z,13Z,16Z,19Z,22Z,25Z-isomer).


9-pentadecenoic acid

A pentadecenoic acid having its double bond in the 9-position.


12-oxo-trans-10-dodecenoic acid

A monounsaturated fatty acid comprising dodecanoic acid having a trans-double bond at the 10-position and a 12-oxo group.


A very long-chain polyunsaturated fatty acid that is tetracosanoic acid having six double bonds located at positions 6, 9, 12, 15, 18 and 21 (the (6Z,9Z,12Z,15Z,18Z,21Z-isomer).


alpha-licanic acid

A trienoic fatty acid comprising alpha-eleostearic acid having a 4-oxo substituent.


vaccenic acid

An octadecenoic acid having a double bond at position 11; and which can occur in cis- or trans- configurations.


dec-9-enoic acid

A decenoic acid having the double bond at position 9.


(9E,11E)-octadecadienoic acid

An octadeca-9,11-dienoic acid having 9-trans,11-trans-stereochemistry.


6-oxohexanoic acid

A medium-chain fatty acid comprising hexanoic acid carrying an oxo group at position 6.


colneleic acid

A long-chain, divinyl ether fatty acid composed of 8-nonenoic acid having the E- hydrogen at position 9 substituted by a (1E,3Z)-nona-1,3,-dien-1-yloxy group.


conjugated linolenic acid

Any n-3 (alpha) or n-6 (gamma)  octadecatrienoic acid in which at least two of the three double bonds are conjugated.


(S)-laballenic acid

The (S)-enantiomer of laballenic acid.


(R)-laballenic acid

The (R)-enantiomer of laballenic acid.


A TriHOME that is (11E)-octadec-11-enoic acid in which the three hydroxy substituents are located at positions 9, 10 and 13.


octadecadienoic acid

Any straight-chain, C18 polyunsaturated fatty acid having two C=C double bonds.


cis-tetradec-7-enoic acid

A tetradecenoic acid having a cis-double bond at the 7-position.


10-pentadecenoic acid

A pentadecenoic acid having its double bond in the 10-position.


(2E)-9-hydroxynon-2-enoic acid

A monounsaturated fatty acid that is (2E)-non-2-enoic acid in which one of the hydrogens at position 9 is replaced by a hydroxy group.


A polyunsaturated fatty acid that is octadecapentaenoic acid in which the five double bonds are located at positions 2, 4, 6, 8 and 10 (the all-trans-geoisomer).


conjugated linoleic acid

An octadecadienoic acid having a system of two conjugated double bonds at any position.


18-hydroxyoleic acid

An omega-hydroxy fatty acid that is 18-hydroxyoctadecanoic acid which has been dehydrogenated to introduce a trans double bond at the 9-10 position.


docosapentaenoic acid

Any straight-chain, C22 fatty acid having five C=C double bonds.


2-bromodecanoic acid

A bromo fatty acid that is decanoic acid carrying a single bromo substituent at position 2.


A very long-chain omega-6 fatty acid that is tetracosanoic acid having four double bonds located at positions 9, 12, 15 and 18 (the 9Z,12Z,15Z,18Z-isomer).


2-tetradecenoic acid

A tetradecenoic acid having its double bond in the 2-position.


tetracosapentaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any five positions of a 24-carbon straight chain.


(Z)-hexadec-11-enoic acid

A C16, monounsaturated fatty acid with a double bond at position 11; a key intermediate in silkworm pheromone biosynthesis.


A hydroxyeicosatrienoic acid that consists of 9E,11Z,14Z-eicosatrienoic acid bearing an 8-hydroxy substituent.


10-nonadecenoic acid

A monounsaturated fatty acid that is nonadecanoic acid with a double bond at position 10.


2-hydroxyhexadecanoic acid

A 2-hydroxy fatty acid comprising a C16 straight chain carrying a hydroxy substituent at position 2.


A very long-chain omega-6 fatty acid that is dotriacontapentaenoic acid having five double bonds located at positions 14, 17, 20, 23 and 26 (the 14Z,17Z,20Z,23Z,26Z-isomer).


9-cis,11-trans-octadecadienoic acid

An octadeca-9,11-dienoic acid having 9-cis,11-trans-stereochemistry.


trans-undec-2-enoic acid

A 2-undecenoic acid in which the olefinic double bond has E configuration.


(2E)-4-hydroxynon-2-enoic acid

A 4-hydroxynon-2-enoic acid in which the double bond has (E)-configuration.


14-hydroxypalmitic acid

A hydroxy fatty acid that is palmitic (hexadecanoic) acid carrying a single hydroxy substituent at position 14.


A very long-chain omega-6 fatty acid that is octacosanoic acid having four double bonds located at positions 13, 16, 19, 22 (the 13Z,16Z,19Z,22Z-isomer).


omega-hydroxytetracosanoic acid

An omega-hydroxy fatty acid that is the 24-hydroxy derivative of tetracosanoic acid.


octacosapentaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any five positions of a 28-carbon straight chain.


(S)-2-hydroxyhexadecanoic acid

The S-enantiomer of 2-hydroxypalmitic acid.


omega-hydroxydotriacontanoic acid

An omega-hydroxy fatty acid that is the 32-hydroxy derivative of dotriacontanoic acid.


(2E)-20-hydroxyicos-2-enoic acid

An omega-hydroxy fatty acid that is trans-2-icosenoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.


all-cis-icosa-11,14,17-trienoic acid

An icosatrienoic acid having three cis- double bonds at positions 11, 14 and 17.


hexatriacontahexaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any six positions of a 36-carbon straight chain.


A 9,11,15-octadecatrienoic acid in which the configuration of the double bonds at positions 9 and 15 is Z, while that of the double bond at position 11 is E.


11,13,15-octadecatrienoic acid

Any octadecatrienoic acid with three fully-conjugated double bonds at positions 11, 13 and 15.


(8Z,11Z,14Z)-heptadecatrienoic acid

A trienoic fatty acid that is heptadecenoic acid having three double bonds located at postions 8, 11 and 14 (the 8Z,11Z,14Z-geoisomer).


octadecatrienoic acid

Any trienoic fatty acid having eighteen carbons.


(R)-2-hydroxyhexadecanoic acid

The R-enantiomer of 2-hydroxypalmitic acid.


(2E)-18-hydroxyoctadec-2-enoic acid

An omega-hydroxy fatty acid that is trans-octadec-2-enoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.


cis-pent-2-enoic acid

A pent-3-enoic acid in cis- configuration.


A very long-chain omega-3 fatty acid that is triacontapentaenoic acid having five double bonds located at positions 15, 18, 21, 24 and 27 (the 15Z,18Z,21Z,24Z,27Z-isomer).


16-hydroxyhexadecanoic acid

An omega-hydroxy-long-chain fatty acid that is hexadecanoic acid (also known as palmitic acid) which is substituted at position 16 by a hydroxy group. It is a key monomer of cutin in the plant cuticle.


2-oxohexadecanoic acid

An oxo fatty acid that is the 2-oxo derivative of hexadecanoic (palmitic) acid.


fatty acid 20:3

Any trienoic fatty acid with twenty carbons.


4-hydroxylauric acid

A hydroxy fatty acid comprising lauric acid carrying a hydroxy group at C-4.


hexadecadienoic acid

Any straight-chain, C16 polyunsaturated fatty acid containing two C=C double bonds (position and geometry not specified).


6-OCTADECYNOIC ACID

An octadecynoic acid having its triple bond at position 6.


trans-11-tetradecenoic acid

The trans-isomer of tetradec-11-enoic acid.


hexatriacontatetraenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any four positions of a 36-carbon straight chain.


An octadecenediynoic acid that is stearic acid with a cis double bond at position 13, two triple bonds at positions 9 and 11, and a hydroxy group at C-8.


hexadecatrienoic acid

Any trienoic fatty acid having sixteen carbons.


trioxilin A3

A trioxilin having (5Z,9E,14Z) double bond configuration; and 8-, (11R)- and (12S)-hydroxy substituents.


lynenic acid

A docosatetraenoic acid carrying four cis-double bonds at positions 10, 13, 16 and 19.


trans-10-pentadecenoic acid

The trans-isomer of pentadec-10-enoic acid.


(2E)-oct-2-enoic acid

An olefinic fatty acid that is octanoic acid carrying a double bond at position 2 (the 2E-isomer).


A very long-chain omega-3 fatty acid that is tetracosanoic acid having five double bonds located at positions 9, 12, 15, 18 and 21 (the (9Z,12Z,15Z,18Z,21Z-isomer).


(5Z,9Z,12Z,15Z)-octadecatetraenoic acid

An octadecatetraenoic acid having four double bonds located at positions 5, 9, 12 and 15 (the all-cis-isomer).


(2E)-11-hydroxyundec-2-enoic acid

An omega-hydroxy fatty acid that is trans-undec-2-enoic acid in which one of the hydrogens attached to the terminal methyl group is replaced by a hydroxy group.


tricosenoic acid

Any C23 monounsaturated fatty acid containing one double bond at an unspecified position.


7-hydroxyheptanoic acid

An omega-hydroxy fatty acid comprising heptanoic acid which is substituted by a hydroxy group at position 7.


A very long-chain omega-3 fatty acid that is dotriacontapentaenoic acid having six double bonds located at positions 14, 17, 20, 23, 26 and 29 (the 14Z,17Z,20Z,23Z,26Z,29Z-isomer).


A HETrE that is (5Z,8Z,11Z)-icosatrienoic acid substituted at position 19 by a hydroxy group.


(10Z)-nonadec-10-enoic acid

The (Z)-stereoisomer of  10-nonadecenoic acid.


(2E)-17-hydroxyheptadec-2-enoic acid

An omega-hydroxy fatty acid that is (2E)-2-heptadecenoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.


dotriacontahexaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any six positions of a 32-carbon straight chain.


(E)-10-hydroxydec-2-enoic acid

An omega-hydroxy amino acid that is 2-decenoic acid in which one of the hydrogens attached to the terminal carbon is replaced by a hydroxy group and in which the C=C double bond has E configuration. It is a component of royal jelly.


9,11,14-octadecatrienoic acid

Any octadecatrienoic acid with three double bonds at positions 9, 11 and 14


(2E)-12-hydroxydodec-2-enoic acid

An omega-hydroxy fatty acid that is trans-2-dodecenoic acid in which one of the hydrogens attached to the terminal methyl group is replaced by a hydroxy group.


A very long-chain omega-6 fatty acid that is octacosanoic acid having five double bonds located at positions 10, 13, 16, 19 and 22 (the 10Z,13Z,16Z,19Z,22Z-isomer).


3-hydroxypalmitic acid

A long-chain fatty acid that is the 3-hydroxy derivative of palmitic acid.


A hydroxy polyunsaturated fatty acid that is (2E,4E,8Z)-tetradeca-2,4,8-trienoic acid which is carrying a hydroxy group at the 6R-position.


pentadecenoic acid

Any C15 straight-chain monounsaturated fatty acid having one C=C double bond.


A HETrE that is (5Z,8Z,11Z)-icosatrienoic acid substituted at position 20 by a hydroxy group.


A very long-chain omega-6 fatty acid that is hexatriacontanoic acid having five double bonds located at positions 18, 21, 24, 27 and 30 (the 18Z,21Z,24Z,27Z,30Z-isomer).


A very long-chain omega-6 fatty acid that is tetracosanoic acid having five double bonds located at positions 6, 9, 12, 15 and 18 (the 6Z,9Z,12Z,15Z,18Z-isomer).


octacosatetraenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any four positions of a 28-carbon straight chain.


A straight-chain polyunsaturated fatty acid composed of eighteen carbons and containing two double bonds, both with Z-geochemistry, at positions 9 and 12 as well as a triple bond at position 6.


colnelenic acid

A long-chain, divinyl ether fatty acid composed of 8-nonenoic acid in which the E-hydrogen at position 9 is substituted by a (1E,3Z,6Z)-nona-1,3,6-trien-1-yloxy group.


(2E,4Z)-8-hydroxydeca-2,4-dienoic acid

A polyunsaturated fatty acid that is deca-2,4-dienoic acid substituted by a hydroxy group at position 8 (the 2E,4Z stereoisomer).


dihomolinoleic acid

A octadecadienoic acid with unsaturation at positions 10 and 12 (the 10Z,12Z-stereoisomer).


A polyunsaturated fatty acid that is tetracosanoic acid having seven double bonds at positions 2, 6, 9, 12, 15, 18 and 21 (the 2E,6Z,9Z,12Z,15Z,18Z,21Z-isomer).


trans-vaccenic acid

The trans- isomer of vaccenic acid.


A very long-chain omega-6 fatty acid that is hexacosanoic acid containing five double bonds located at positions 8, 11, 14, 17 and 20 (the 8Z,11Z,14Z,17Z,20Z-isomer).


A very long-chain omega-3 fatty acid that is hexatriacontanoic acid having six double bonds located at positions 18, 21, 24, 27, 30 and 33 (the 18Z,21Z,24Z,27Z,30Z,33Z-isomer).


cis-9-nonadecenoic acid

A monounsaturated fatty acid that is nonadecanoic acid that has been dehydrogenated to introduce a double bond with Z configuration between the carbons at positions 9 and 10. It has been isolated from the spores of reishi mushroom, Ganoderma lucidum, and found to inhibit tumour cell proliferation and induce apoptosis of HL-60 cells.


A conjugated linolenic acid having three fully-conjugated double bonds at positions 9, 11 and 13, in cis, trans and trans configurations, respectively.


2-decenoic acid

A decenoic acid having its double bond in position 2.


(9Z)-pentadecenoic acid

A 9-pentadecenoic acid in which the double bond adopts cis-configuration.


(2E)-19-hydroxynonadec-2-enoic acid

An omega-hydroxy fatty acid that is 19-hydroxynonadecanoic acid which has been dehydrogenated to introduce a trans double bond at the 2-3 position.


octadeca-9,12-diynoic acid

An octadecadiynoic acid having its triple bonds at positions 9 and 12.


octatriacontatetraenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any four positions of a 38-carbon straight chain.


butenoic acid

Any C4, straight-chain fatty acid containing one double bond.


(5Z,7E,9E,14Z,17Z)-icosapentaenoic acid

The (5Z,7E,9E,14Z,17Z)-isomer of icosapentaenoic acid.


(9E)-tetradecenoic acid

A tetradecenoic acid that is the E-geoisomer of tetradec-9-enoic acid.


cis-tetradec-5-enoic acid

A straight-chain, monounsaturated, 14-carbon long-chain fatty acid with a cis-double bond at position C-5


A very long-chain omega-3 fatty acid that is triacontahexaenoic acid having six double bonds located at positions 12, 15, 18, 21, 24 and 27 (the 12Z,15Z,18Z,21Z,24Z,27Z-isomer).


(17Z)-hexacosenoic acid

A very long-chain monounsaturated fatty acid that is hexacosanoic acid having a double bond at position 17 (the Z-isomer).


octadeca-10,12-diynoic acid

An octadecadiynoic acid having its triple bonds at positions 10 and 12.


hexacosatetraenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any four positions of a 26-carbon straight chain.


all-cis-7,10,13-hexadecatrienoic acid

A hexadecatrienoic acid having Z double bonds at positions 7, 10 and 13.


(R)-4-hydroxylauric acid

An optically active form of 4-hydroxylauric acid having (R)-configuration.


pent-2-enoic acid

A pentenoic acid having the double bond at position 2.


dodecadienoic acid

A C12, polyunsaturated acid carrying two double bonds at any position.


(5Z)-5-octenoic acid

An olefinic fatty acid that is octanoic acid carrying a double bond at position 5 (the 5Z-isomer).


(7Z,10Z)-hexadecadienoic acid

A hexadecadienoic acid having two double bonds located at positions 7 and 10 (the 7Z,10Z-geoisomer).


(9Z)-heptadecenoic acid

A heptadecenoic acid in which the double bond is located at the 9-10 position and has Z configuration.


mycomycin

A straight-chain polyunsaturated fatty acid comprising tridecanoic acid having (E)- and (Z)-double bonds at positions 3 and 5 respectively, an allenic system at positions 7-9 and triple bonds at positions 10 and 12.


A very long-chain omega-3 fatty acid that is tetratriacontapentaenoic acid having five double bonds located at positions 19, 22, 25 ,28 and 31 (the 19Z,22Z,25Z,28Z,31Z-isomer).


7-tetradecenoic acid

A tetradecenoic acid having its double bond in the 7-position.


(5Z,8Z,11Z)-icosatrienoic acid

A 5,8,11-eicosatrienoic acid in which all three double bonds adopt cis-configuration.


dotriacontatetraenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any four positions of a 32-carbon straight chain.


A very long-chain omega-3 fatty acid that is hexatriacontanoic acid having five double bonds located at positions 21, 24, 27, 30 and 33 (the 21Z,24Z,27Z,30Z,33Z-isomer).


10-hydroxypalmitic acid

A hydroxypalmitic acid that is palmitic (hexadecanoic) acid carrying a single hydroxy substituent at position 10.


trans-2-hexacosenoic acid

The trans-isomer of 2-hexacosenoic acid


22-tricosenoic acid

A tricosenoic acid having a double bond at position 22.


(2E)-7-hydroxyhept-2-enoic acid

An omega-hydroxy fatty acid that is trans-2-heptenoic acid in which one of the hydrogens of the terminal methyl group is replaced by a hydroxy group.


VACCENIC ACID

The cis isomer of vaccenic acid.


hexadec-9-enoic acid

A hexadecenoic acid in which the double bond is located at position 9.


A very long-chain omega-3 fatty acid that is octacosanoic acid having five double bonds located at positions 13, 16, 19, 22 and 25 (the 13Z,16Z,19Z,22Z,25Z-isomer).


A polyunsaturated fatty acid that is hexadeca-2,4,8,10-tetraenoic acid substituted by a hydroxy group at position 7. All 4 double bonds have E- (trans-) geometry.


jalapinolic acid

A hydroxypalmitic acid that is palmitic acid substituted by hydroxy group at position 11 (the 11S stereoisomer).


A hydroxyeicosatrienoic acid that consists of 8Z,11Z,13E-icosatrienoic acid bearing an additional 15-hydroxy substituent.


A  polyunsaturated fatty acid that is icosanoic acid having unsaturation at positions 2, 5, 8, 11, 14 and 17. It has been found in  Daphnia galeata.


sapienic acid

A hexadecenoic acid in which the double bond is located at position 6 (the Z-geoisomer). A major component of human sebaceous lipids that is involved in skin self-sterilisation and atopic dermatitis amelioration.


(9E)-pentadecenoic acid

A 9-pentadecenoic acid in which the double bond adopts trans-configuration.


The all-cis-isomer of a C22 polyunsaturated fatty acid having five double bonds in the 4-, 7-, 10-, 13- and 16-positions. It is a member of n-6 PUFA and a product of linoleic acid metabolism.


tetratriacontapentaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any five positions of a 34-carbon straight chain.


octadecenynoic acid

Any C18 polyunsaturated fatty acid containing one C=C and one C#C bond.


9,11,15-octadecatrienoic acid

Any octadecatrienoic acid with three double bonds at positions 9, 11 and 15.


(3E,5Z)-tetradecadienoic acid

A long-chain polyunsaturated fatty acid that is tetradecanoic acid containing two double bonds at positions 3 and 5 (the 3E,5Z-geoisomer).


octacosahexaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any six positions of a 28-carbon straight chain.


HETrE

A long-chain polyunsaturated fatty acid that is any icosatrienoic acid bearing a single hydroxy substituent. An oxidation product of icosatrienoic acid metabolism.


cetoleic acid

A docosenoic acid having a cis-double bond at position 11.


(4Z)-hexadecenoic acid

A hexadecenoic acid with a cis-double bond at position C-4.


2-hexacosenoic acid

A hexacosenoic acid with the double bond at the 2-position.


2-undecenoic acid

An undecenoic acid having its double bond in the 2-position.


cis-4-decenoic acid

A decenoic acid having a cis- double bond at position 4.


A very long-chain omega-3 fatty acid that is dotriacontapentaenoic acid having five double bonds located at positions 17, 20, 23, 26 and 29 (the 17Z,20Z,23Z,26Z,29Z-isomer).


laballenic acid

A C18, 5,6-allenic fatty acid.


cerebronic acid

A very long-chain hydroxy fatty acid composed of lignoceric acid having a 2-hydroxy substituent.


A polyunsaturated fatty acid that is deca-2,8-dien-4-ynoic acid substituted at position 10 by a hydroxy group (the 2E,8E-geoisomer)


linoelaidic acid

An octadecadienoic acid containing two E (trans) double bonds at positions 9 and 12.


(Z)-hexadec-7-enoic acid

A C16 fatty acid having a (Z)-double bond at the 7-position; marker of early life stage mortality in trout and of physiologically active autotrophic bacteria in complex microbial communities.


(2E)-14-hydroxytetradec-2-enoic acid

An omega-hydroxy fatty acid that is trans-2-tetradecenoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.


stearolic acid

An octadecynoic acid having its triple bond at position 9.


DICRANIN

A trienoic fatty acid, that is octadecanoic acid containing double bonds at positions 9, 12 and 15 and a triple bond at position 6. Isolated from Dicranum scoparium, it exhibits antibacterial activity and inhibitory activity against arachidonate 15-lipoxygenase.


(9Z)-hexacosenoic acid

A hexacosenoic acid in which the double bond is located at position 9 and has Z configuration.


tetratriacontatetraenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any four positions of a 34-carbon straight chain.


11-hydroxyundecanoic acid

An omega-hydroxy fatty acid that is undecanoic acid in which one of the hydrogens of the terminal methyl group is replaced by a hydroxy group.


9,11,13-octadecatrienoic acid

Any octadecatrienoic acid with three fully-conjugated double bonds at positions 9, 11 and 13.


triacontapentaenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any five positions of a 30-carbon straight chain.


A very long-chain omega-6 fatty acid that is tetratriacontapentaenoic acid having five double bonds located at positions 16, 19, 22, 25 and 28 (the 16Z,19Z,22Z,25Z,28Z-isomer).


cis-9-undecenoic acid

The cis-isomer of 9-undecenoic acid.


(5Z,9Z,12Z)-octadecatrienoic acid

An octadecatrienoic acid having three double bonds located at positions 5, 9 and 12 (the all-cis-isomer).


pentenoic acid

Any C5, straight-chain, monounsaturated fatty acid.


ambrettolic acid

An omega-hydroxy-long-chain fatty acid that is hexadec-7-enoic acid carrying a hydroxy group at position 16.


triacontatetraenoic acid

A polyunsaturated fatty acid whose structure contains double bonds at any four positions of a 30-carbon straight chain.


4-hydroxynon-2-enoic acid

A medium-chain fatty acid that is non-2-enoic acid substituted at position 4 by a hydroxy group.


(2E)-16-hydroxyhexadec-2-enoic acid

An omega-hydroxy fatty acid that is trans-2-hexadecenoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.


An octadecatetraenoic acid having four double bonds located at positions 6, 9, 12 and 15 (the all-cis-isomer). It has been isolated from Lithospermum officinale and fish oils.


tetracosenoic acid

Any C24 monounsaturated fatty acid containing one double bond.